Ponoi II Management, LLC
- SEC CIK
- 0001746488
- Latest filing
- Nov 14, 2022
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 11, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 4
- 0 vs. Q3 2021
- Portfolio value
- $55.1M
- −$12.4M (−18.4%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NGMNGM Biopharmaceuticals Inc | COM | 1,298,908 | $23.0M | 41.8% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 685,011 | $17.2M | 31.3% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 327,123 | $9.47M | 17.2% | −234,451−41.7% | Reduced | History |
| RAPTRAPT Therapeutics, Inc. | COM | 145,401 | $5.34M | 9.7% | 00.0% | Unchanged | History |